Chitosan‐based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy
M Ashrafizadeh, K Hushmandi… - Bioengineering & …, 2023 - Wiley Online Library
Green chemistry has been a growing multidisciplinary field in recent years showing great
promise in biomedical applications, especially for cancer therapy. Chitosan (CS) is an …
promise in biomedical applications, especially for cancer therapy. Chitosan (CS) is an …
[HTML][HTML] Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer
Cancer often develops multidrug resistance (MDR) when cancer cells become resistant to
numerous structurally and functionally different chemotherapeutic agents. MDR is …
numerous structurally and functionally different chemotherapeutic agents. MDR is …
[PDF][PDF] Prostaglandin pathways: opportunities for cancer prevention and therapy
Because of profound effects observed in carcinogenesis, prostaglandins (PGs),
prostaglandin-endoperoxide synthases, and PG receptors are implicated in cancer …
prostaglandin-endoperoxide synthases, and PG receptors are implicated in cancer …
[HTML][HTML] The role of Th17 cells in the pathogenesis and treatment of breast cancer
V Karpisheh, M Ahmadi, K Abbaszadeh-Goudarzi… - Cancer Cell …, 2022 - Springer
Breast cancer is a severe problem worldwide due to an increase in mortality and prevalence
among women. Despite early diagnostic procedures as well as advanced therapies, more …
among women. Despite early diagnostic procedures as well as advanced therapies, more …
RGD-decorated PLGA nanoparticles improved effectiveness and safety of cisplatin for lung cancer therapy
Upon extensive pharmaceutical and biomedical research to treat lung cancer indicates that
lung cancer remains one of the deadliest diseases and the leading cause of death in men …
lung cancer remains one of the deadliest diseases and the leading cause of death in men …
The role of regulatory T cells in the pathogenesis and treatment of prostate cancer
V Karpisheh, SM Mousavi, PN Sheykholeslami, M Fathi… - Life sciences, 2021 - Elsevier
Despite developments in the treatment of various cancers, prostate cancer is one of the
deadliest diseases known to men. Systemic therapies such as androgen deprivation …
deadliest diseases known to men. Systemic therapies such as androgen deprivation …
[HTML][HTML] Chitosan–hyaluronic acid nanoparticles for active targeting in cancer therapy
LE Puluhulawa, IM Joni, KM Elamin, AFA Mohammed… - Polymers, 2022 - mdpi.com
Cancer is the most common cause of death worldwide; therefore, there is a need to discover
novel treatment modalities to combat it. One of the cancer treatments is nanoparticle …
novel treatment modalities to combat it. One of the cancer treatments is nanoparticle …
[HTML][HTML] Nanovaccines for cancer prevention and immunotherapy: an update review
X Fang, H Lan, K Jin, D Gong, J Qian - Cancers, 2022 - mdpi.com
Simple Summary Cancer vaccines are a promising immunotherapy-based agents used in
cancer therapy. However, monotherapy with these vaccines does not have the sufficient …
cancer therapy. However, monotherapy with these vaccines does not have the sufficient …
Blockade of HIF-1α and STAT3 by hyaluronate-conjugated TAT-chitosan-SPION nanoparticles loaded with siRNA molecules prevents tumor growth
HS Budi, S Izadi, A Timoshin, SH Asl, B Beyzai… - … , Biology and Medicine, 2021 - Elsevier
HIF-1α and STAT3 are two of the critical factors in the growth, proliferation, and metastasis of
cancer cells and play a crucial role in inhibiting anti-cancer immune responses. Therefore …
cancer cells and play a crucial role in inhibiting anti-cancer immune responses. Therefore …
Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression
Aims Despite extensive efforts to find new treatments, chemotherapy is still one of the first
and foremost choices for cancer treatment. The main problems of using these drugs are the …
and foremost choices for cancer treatment. The main problems of using these drugs are the …